Login / Signup

Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.

Anne-Gaëlle DosneElodie ValadeNele GoeyvaertsPeter De PorreAnjali AvadhaniAnne O'HaganLilian Y LiDaniele OuelletJuan Jose Perez Ruixo
Published in: Cancer chemotherapy and pharmacology (2022)
NCT02365597.
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • rectal cancer
  • neoadjuvant chemotherapy
  • small cell lung cancer
  • radiation therapy
  • phase ii study
  • open label